Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Diabetes medicines

FDA

Sulfonylureas

Tolazamide

OralTablet

The FDA lists this product in 33 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: TOLAZAMIDE 250MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

TOLAZAMIDE 500MG · TabletANDA070169-001 · Discontinued
TOLAZAMIDE 100MG · TabletANDA070242-001 · Discontinued
TOLAZAMIDE 250MG · TabletThis page
TOLAZAMIDE 500MG · TabletNDA018894-003 · Discontinued
TOLAZAMIDE 100MG · TabletNDA018894-001 · Discontinued
TOLAZAMIDE 250MG · TabletNDA018894-002 · Discontinued
TOLAZAMIDE 250MG · TabletANDA070168-001 · Discontinued
TOLAZAMIDE 100MG · TabletANDA070513-001 · Discontinued
TOLAZAMIDE 500MG · TabletANDA070764-001 · Discontinued
TOLAZAMIDE 100MG · TabletANDA071355-001 · Discontinued
TOLAZAMIDE 500MG · TabletANDA070167-001 · Discontinued
TOLAZAMIDE 250MG · TabletANDA070289-001 · Discontinued
TOLAZAMIDE 100MG · Tablet

More in diabetes medicines

DapagliflozinTablet
Dapagliflozin and Metformin Hydrochloridedapagliflozin · Tablet, extended release

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA070159-001 · Discontinued

TOLAZAMIDE 100MG · TabletANDA070165-001 · Discontinued

TOLAZAMIDE 250MG · TabletANDA070166-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA071359-001 · Discontinued

TOLAZAMIDE 100MG · TabletANDA071633-001 · Discontinued

TOLAZAMIDE 250MG · TabletANDA070163-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA070290-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA070164-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA070244-001 · Discontinued

TOLAZAMIDE 250MG · TabletANDA071358-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA070259-003 · Discontinued

TOLAZAMIDE 250MG · TabletANDA070259-001 · Discontinued

TOLAZAMIDE 100MG · TabletANDA071357-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA070161-001 · Discontinued

TOLAZAMIDE 250MG · TabletANDA070243-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA070515-001 · Discontinued

TOLAZAMIDE 250MG · TabletANDA070763-001 · Discontinued

TOLAZAMIDE 500MG · TabletANDA071271-001 · Discontinued

TOLAZAMIDE 250MG · TabletANDA070160-001 · Discontinued

TOLAZAMIDE 100MG · TabletANDA070162-001 · Discontinued

TOLAZAMIDE 250MG · TabletANDA070514-001 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA071270.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Tolazamide
Drug class: Sulfonylureas
Group: Diabetes medicines
Route: Oral
Dosage form: Tablet
Applicant: Interpharm
Status: Discontinued
Application: ANDA071270-001
RxCUI: 10633

Guidelines

Guidelines in endocrinology and metabolism950 guidelines in the library

FDA 2026Dapagliflozin and Saxagliptin Hydrochloridedapagliflozin · Tablet

FDA 2025Wegovysemaglutide · Tablet

FDA 2025Sitagliptin and Metformin Hydrochloridemetformin hydrochloride · Tablet

FDA 2025Kirstyinsulin aspart-xjhz · Injection

FDA 2024LiraglutideSolution

FDA 2024Sitagliptin and Metformin HCLsitagliptin, metformin hydrochloride · Tablet

FDA 2024Zituvimet XRmetformin hydrochloride · Tablet, extended release

FDA 2023Zepboundtirzepatide · Solution

FDA 2023Zepbound (Autoinjector)tirzepatide · Solution

FDA 2023Zepbound Kwikpentirzepatide · Solution

FDA 2023Zituvimetmetformin hydrochloride · Tablet

FDA 2023Zituviositagliptin · Tablet

FDA 2023Saxagliptin and Metformin Hydrochloridemetformin hydrochloride · Tablet, extended release

FDA 2023Saxagliptinsaxagliptin hydrochloride · Tablet

FDA 2023Inpefasotagliflozin · Tablet

FDA 2023Brenzavvybexagliflozin · Tablet